| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 18, 2025 | Sell(S) | 6K | $0.63 | $4K | 321K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-023192) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Karyopharm Therapeutics Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.